Efficacy and safety of epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKI) monotherapy for advanced EGFR-mutated non-small cell lung cancer: systematic review and meta-analysis.

Lee, H J; Jeong, G H; Li, H; Kim, M S; Kim, J S; Park, S J; Han, Y J; Lee, K H; Kronbichler, A; Hong, S H; Ghayda, R A; Luchini, C; Nottegar, A; Koyanagi, A; Smith, L; Jacob, L; Dragioti, E; Radua, J; Cargnin, S; Terrazzino, S; Thompson, T; Yon, D K; Lee, S W; Yang, J M; Wasuwanich, P; Shin, J I; Gamerith, G

Lee, H J; Jeong, G H; Li, H; Kim, M S; Kim, J S; Park, S J; Han, Y J; Lee, K H; Kronbichler, A; Hong, S H; Ghayda, R A; Luchini, C; Nottegar, A; Koyanagi, A; Smith, L; Jacob, L; Dragioti, E; Radua, J; Cargnin, S; Terrazzino, S; Thompson, T; Yon, D K; Lee, S W; Yang, J M; Wasuwanich, P; Shin, J I; Gamerith, G.

Affiliation

Lee HJ; Yonsei University College of Medicine, Seoul, Republic of Korea. shinji@yuhs.ac.

Eur Rev Med Pharmacol Sci ; 25(20): 6232-6244, 2021 Oct.

Article in En | MEDLINE | ID: mdl-34730203

Subject(s)

Carcinoma, Non-Small-Cell Lung/drug therapy; Lung Neoplasms/drug therapy; Protein Kinase Inhibitors/pharmacology; Antineoplastic Agents/adverse effects; Antineoplastic Agents/pharmacology; Carcinoma, Non-Small-Cell Lung/genetics; ErbB Receptors/antagonists & inhibitors; ErbB Receptors/genetics; Humans; Lung Neoplasms/genetics; Mutation; Progression-Free Survival; Protein Kinase Inhibitors/adverse effects; Survival Rate

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Non-Small-Cell Lung / Protein Kinase Inhibitors / Lung Neoplasms Type of study: Prognostic_studies / Systematic_reviews Limits: Humans Language: En Journal: Eur Rev Med Pharmacol Sci Journal subject: FARMACOLOGIA / TOXICOLOGIA Year: 2021 Document type: Article Country of publication: Italy

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google